NASDAQ · Drug Manufacturers - Specialty & Generic · USD
Caring Brands, Inc. (CABR) Stock Analysis
Caring Brands, Inc. (CABR) is a Drug Manufacturers - Specialty & Generic stock listed on NASDAQ and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
CABR Key Statistics
As of Oct 21, 2026Trading
- Open
- $1.06
- Previous Close
- $1.07
- Day's Range
- 1.06–1.10
- 52-Week Range
- 0.71–1.84
- Volume
- 1.20K
Valuation
- Market Cap
- $13.89M
- P/E Ratio
- unprofitable
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −0.78
Financials (FY)
- Revenue (FY)
- $4.22K+806.45%
- Net Income (FY)
- −$6.28M
- Shares Outstanding
- 10.37M
Dividend and dates
- Avg Volume
- 52.36K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
Caring Brands, Inc. (CABR) has a market capitalization of $13.89M.
In fiscal 2025, CABR reported revenue of $4.22K.
CABR Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +28.21% |
| 2025 (partial year) | +3.00% |
As of October 21, 2026.
CABR Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $4.22K | −$6.28M | −148,948.8% |
| 2024 | $465.00 | −$1.52M | −326,329.2% |
| 2023 | $20.42K | −$128.09K | −627.2% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $4.22K | $2.34K | −$3.39M | −$6.28M | −148,948.8% |
| 2024 | $465.00 | −$1.61K | −$1.53M | −$1.52M | −326,329.2% |
| 2023 | $20.42K | −$98.45K | −$151.39K | −$128.09K | −627.2% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
Recent News
Caring Brands Chairman, Interim CFO Brian John Departs, Effective Sept. 16; CEO Glynn Wilson Appointed Board Chairman, Brian R. Meadows As CFO
BenzingaCaring Brands Inc. (Nasdaq: CABR) Completes Initial $4.6 Million Closing Under Ongoing $9 Million Private Placement
YahooCaring Brands Announces Its IP Portfolio Now Includes Five Issued U.S. Patents Covering Two Of Its Main Product Platforms, Hair Enzyme Booster And Photocil
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Drug Manufacturers - Specialty & Generic Stocks
Takeda Pharmaceutical Company Limited
$63.67B
TEVATeva Pharmaceutical Industries Limited
$47.37B
HLNHaleon plc
$44.06B
ZTSZoetis Inc.
$32.90B
UTHRUnited Therapeutics Corporation
$24.17B
VTRSViatris Inc.
$21.19B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B


